IFAH-Europe first reaction to vote in ENVI Committee on the Proposal for a Regulation on Veterinary Medicines

Written by IFAH-Europe on 19 February 2016 in Press Release
Press Release

IFAH-Europe welcomes the efforts of the rapporteur and the members of the Environment Committee of the European Parliament in their review of the Commission’s proposal for a Regulation on veterinary medicinal products.

Brussels, 18 February 2016 – IFAH-Europe welcomes the efforts of the rapporteur and the members of the Environment Committee of the European Parliament in their review of the Commission’s proposal for a Regulation on veterinary medicinal products. Overhauling this piece of legislation - an opportunity that only comes every 10 years or so - is of great importance not only for Europe’s animals, farmers and pet owners but also for the health of its citizens and for the European agri-food sector.

The Environment Committee of the European Parliament (ENVI) in its first reading of the proposal has made some very welcome amendments that aim to increase the availability of veterinary medicines for farmers and pet owners, reduce the administrative burden to streamline the regulatory process for industry, and stimulate innovation to offer new solutions for combatting animal disease.

The question now is whether the amendments go far enough to truly spur the much-needed impetus for innovating disease prevention and treatment options. For minor species for example, such as goats, where there is a lack of treatment options, there is a clear need for improved data protection to encourage companies to continue investing in new medicines beyond the 'first' species so that they may be used for several species.

Commenting after the Committee vote on 17 February, IFAH-Europe Secretary General Roxane Feller said, “Veterinary medicines are an important part of any veterinarian’s toolbox so it is vital that amendments to this key piece of legislation support the need for innovation and availability of medicines. We welcome the work done so far and strongly advocate the responsible use of all medicines in veterinary care. We fully support the banning of the routine prophylactic use of antibiotics and continue to promote the responsible use of antibiotics in farm animals hand in hand with excellent hygiene, biosecurity and good husbandry on farms.”

 

About the author

IFAH-Europe is the representative body of manufacturers of veterinary medicines, vaccines and other animal health products in Europe. It promotes a single market in veterinary medicines across the EU, ensuring availability of medicines to protect the health and welfare of animals. For further information on IFAH-Europe, please visit www.ifaheurope.org or follow us on twitter @IFAHEurope or Facebook: We Care

 

For further press information please contact

Kim Hardie, Communications Director
Tel: +32 2 543 75 75
E-mail: k.hardie@ifahsec.org

Share this page

Tags

Categories

Partner content

This content is published by the Parliament Magazine on behalf of our partners.

Related Articles

Issue 468 | 22 January 2018
19 January 2018

Jerzy Buzek interview, European Space Policy, World Cancer Day, Copyright, Mental Health, Clean Energy and Mobility, Bisphenol A, Research and Innovation Funding, Poland and the...

Much more needs to be done to bridge the ‘gap’ in transition from child to adult mental healthcare
19 January 2018

Much more needs to be done to bridge the ‘gap’ in transition from child to adult mental healthcare, MEPs have been told.

Parliament to set up pesticides committee
18 January 2018

MEPs have welcomed the decision to set up a special committee to look into the EU’s authorisation procedure for pesticides.

Related Partner Content

Thought Leader: Juan Jover: Early intervention
31 March 2014

Early intervention is a cost-effective solution to reducing the burden of musculoskeletal disorders, writes Juan Jover.

Will Europe embrace precise plant breeding or further frustrate innovation?
18 September 2017

We urgently need legal certainty to support innovation in plant breeding in the EU, writes Arjen van Tunen. 

Data protection regulation set to benefit patient health
4 December 2015

A balanced approach to data protection in research will boost patient health, writes Richard Bergström.